NCT01647217View on ClinicalTrials.gov

Demodex Blepharitis Treatment Study

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

July 31, 2015

Conditions
Chronic Blepharitis
Interventions
DRUG

Terpinen-4-ol

Lid scrub once or twice per day for one month.

OTHER

Placebo

Lid scrub once or twice per day for one month

Trial Locations (1)

33173

Ocular Surface Center, Miami

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

BioTissue Holdings, Inc

INDUSTRY

NCT01647217 - Demodex Blepharitis Treatment Study | Biotech Hunter | Biotech Hunter